Epredia expands its Anatomical Pathology division in Europe through the acquisition of Microm Microtech France and Laurypath
Epredia, a leader in the field of precision cancer diagnostics, announced today that Microm Microtech France (MMFrance) and Laurypath, two anatomical pathology segment supplier companies, have been acquired by Epredia’s parent company, PHC Holdings Corporation [TSE 6523], as part of…